ATRCAtriCure, Inc.
47.93USD+0.67%Mkt Cap: 2.42B $P/E: 226.71

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to …

Key Statistics

Company
Market Cap2.42B $
Enterprise Value2.32B $
Revenue (TTM)569.62M $
Gross Profit400.78M $
Net Income (TTM)-11.45M $
Revenue/Share11.81 USD
Last Price47.93 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)226.71
P/E (Forward)109.99
PEG10.00
EV/EBITDA68.81
EV/Revenue4.08
P/S4.24
P/B4.68
EPS (TTM)0.21
EPS (Forward)0.43
52W Range
25.37100% of range47.98
52W High47.98 USD
52W Low25.37 USD
Profitability
Gross Margin74.98%
Oper. Margin6.29%
EBITDA Margin5.92%
Profit Margin-2.14%
ROE-2.33%
ROA-1.75%
Growth
Revenue Growth12.80%
Earnings Growth
Cash Flow & Leverage
Operating CF57.33M $
CapEx (TTM)15.05M $
FCF Margin8.57%
FCF Yield2.02%
Net Debt-93.56M $
Net Debt/EBITDA-2.77
Balance Sheet
Debt/Equity0.15
Current Ratio4.22
Quick Ratio3.02
Book Value/Sh10.15 USD
Cash/Share3.299 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)47.33 USD
Upside (mean)-1.2%
Target Range36.00 USD55.00 USD
$36.00-1.2% to mean$55.00
# Analysts9
Ownership
Shares Out.50.87M
Float48.80M
Insiders3.81%
Institutions105.97%
Short Interest
Short Ratio4.0d
Short % Float7.91%
Short % Out.7.60%
Shares Short3.86M
Short (prev mo.)4.45M
Technical
SMA 5035.33 (+35.7%)
SMA 20033.58 (+42.7%)
Beta1.23
S&P 52W Chg18.16%
Avg Vol (30d)824.17K
Avg Vol (10d)660.90K
Technical Indicators
RSI (14)82.1
MACD3.1471
MACD Signal2.7111
MACD Hist.+0.4360
BB Upper47.70 USD
BB Middle40.19 USD
BB Lower32.67 USD
BB Width37.41%
ATR (14)1.796 USD
Vol Ratio (20d)1.06x